| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |